J Pharmacol Exp Ther 351:114123
Gastrointestinal Conditions BPC-157 was originally isolated from gastric juice, and its most robust preclinical evidence involves gastrointestinal healing
At 30 min after isoprenaline 75 mg/kg s.c., we noted an early multiorgan failure (brain, heart, lung, liver, kidney and gastrointestinal lesions), thrombosis, intracranial (superior sagittal sinus) hypertension, portal and caval hypertension, and aortal hypotension, full presentation (or attenuation by BPC 157 therapy (given at 5 min after isoprenaline) via activation of the azygos vein) (Figure 1, Figure 2, Figure 3, Figure 4, Figure 5, Figure 6, Figure 7, Figure 8 and Figure 9)
If excess FAs are deposited in ectopic tissues, this could lead to lipotoxic effects of FAs
Moderate, physiological elevation from secretagogues differs from supraphysiological HGH doses, but the theoretical concern exists
This product is for research purposes only